Allergan's Price Reform Pledge: Will Others Follow?

Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.

Allergan PLC CEO Brent Saunders on Sept. 6 vowed his company won't be among the "outliers" in the biopharmaceutical industry that have dramatically jacked up the prices of their medicines or engaged in price gouging – declaring the firm has a solid social contract with patients against doing so.

"Those who have taken aggressive or predatory price increases have violated this social contract," Saunders wrote

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Drug Pricing

More from Scrip